View monthly record counts
| Month | Records |
|---|---|
| 2 | |
| 4 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 10 |
Data updated:
| Month | Records |
|---|---|
| 2 | |
| 4 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 10 |
| # | Country / Region | Records |
|---|---|---|
| 1 | India | 14 |
| 2 | Colombia | 2 |
| # | HS Code | Description (CN) | Description (EN) | Records |
|---|---|---|---|---|
| 1 | 382290 | 有证标准样品 | Certified reference sample | 8 |
| 2 | 300215 | 免疫制品,已配定剂量或制成零售包装 | Immunological products, put up in measured doses or in forms or packings for retail sale | 6 |
| 3 | 294190 | 其他抗菌素 | Antibiotics (excluding penicillins and their derivatives with a penicillanic acid structure, salts thereof, streptomycins, tetracyclines, chloramphenicol and erythromycin, their derivatives and salts thereof) | 1 |
| # | Partner Name | Country / Region | Records |
|---|---|---|---|
| 1 | FUTURIS HEALTHCARE LLP | INDIA | 14 |
| 2 | FUND CARDIOVASCULAR DE COLOMBIA | — | 2 |
| Date | Jan 23, 2023 | Bill No. | — | ||
|---|---|---|---|---|---|
| Supplier Information | Company Name | CELL SYSTEMS | Buyer Information | Company Name | FUTURIS HEALTHCARE LLP |
| Address | — | Address | — | ||
| Registration No. | — | Registration No. | 0315014491 | ||
| Phone | — | Phone | — | ||
| — | — | ||||
| Product Information | HS Code | 30021500 | HS Description | 免疫制品,已配定剂量或制成零售包装Immunological products, put up in measured doses or in forms or packings for retail sale | |
| Product Description | ACBRI 181 PRIMARY HUMAN RETINAL MICROVASCULAR ENDOTHELIAL CELLS PASSAGE3 VIAL FOR LABORATORY RESEARCH PURPOSES ONLY | Brand | — | ||
| Quantity & Price | Amount | 633.75 | Weight | — | |
| Quantity | 1 PCS | TEU | — | ||
| Shipment Information | Origin Country | UNITED STATES | Destination Country | INDIA | |
| Port of Loading | — | Destination Port | — | ||
| Loading Place | — | Transport Mode | UNKNOWN | ||
| Transaction Mode | — | Carrier | — | ||
| Vessel Name | — | Voyage | — | ||
| Container No. | — | Shipping Country | — | ||